LGND

NASDAQ 已收盘

Ligand Pharmaceuticals

286.94 USD
▼-11.77-3.94%
盘后 288.43 +0.52%
2026-11-19
市值
$5.76B
市盈率
120.31
EPS
2.39
股息率
—
52 周区间
175.89 – 326.63
成交量
168.87K
Beta
1.03
目标价
361.27
52W 低 175.8952W 高 326.63
价格走势

公司简介

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteopor...